Brookline, MA, United States of America

Fabien Dépis

USPTO Granted Patents = 2 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2023-2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Fabien Dépis: Innovator in Antibody Development

Introduction

Fabien Dépis is a notable inventor based in Brookline, MA (US), recognized for his contributions to the field of biotechnology. He holds two patents that focus on innovative methods for producing antibodies that target specific human chemokine receptors.

Latest Patents

His latest patents include "Nucleic acids encoding, and methods of producing, antibodies that bind human chemokine (C—C motif) receptor 8 (CCR8)." This patent outlines various embodiments related to antibodies and fusion proteins that can be utilized in treating conditions such as cancer. Another significant patent is "Antibodies that bind chemokine (C-C motif) receptor 8 (CCR8)," which also details antibodies and fusion proteins aimed at CCR8, emphasizing their potential therapeutic applications.

Career Highlights

Fabien Dépis is currently employed at Gilead Sciences, Inc., where he continues to advance research in antibody development. His work is pivotal in the ongoing efforts to create effective treatments for various diseases, particularly cancer.

Collaborations

He collaborates with esteemed colleagues, including Changyun Hu and Leonard G Presta, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Fabien Dépis exemplifies the spirit of innovation in biotechnology through his groundbreaking patents and collaborative efforts. His work has the potential to significantly impact the treatment of cancer and other diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…